MARKET WIRE NEWS

Top 4 NASDAQ Genetics Stocks (Updated January 2026)

Source: Investing News Network

2026-01-07 16:15:00 ET

Discoveries made by companies in the genetics sector help support every other life science industry in a variety of ways.

One of the genetic sector's major contributions is the discovery of new genetic drivers of diseases. Genetic testing has grown substantially over the last few years, thanks to advances in technology; growth has also been spurred by an increase in chronic diseases and the continuing development of test kits for therapeutic areas with unmet medical needs.

Gene therapy is also a huge driver of growth in the overarching genetics market. This important segment of the life science market is focused on how genes can help treat or prevent serious conditions in patients. This includes the potential for healthcare professionals to implement gene therapy at the cellular level instead of using medication or surgery, replacing "faulty" genes with new ones to potentially cure diseases.

For further details see:

Top 4 NASDAQ Genetics Stocks (Updated January 2026)
Avidity Biosciences Inc.

NASDAQ: RNA

RNA Trading

-3.96% G/L:

$13.95 Last:

365,705 Volume:

$14.47 Open:

mwn-ir Ad 300

RNA Latest News

RNA Stock Data

$10,978,987,941
124,608,839
0.38%
98
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App